Abstract:Background: Accurate diagnosis of highly aggressive papillary thyroid cancer (PTC) may greatly help avoid overdiagnosis and overtreatment of PTC. However, there is still a lack of a convenient and accurate method. Targeted microbubbles, an emerging ultrasound contrast agent, have the potential to accurately diagnose highly aggressive PTC. Purpose: To design and prepare a targeted microbubble for specific contrast-enhanced ultrasound (CEUS) imaging of highly invasive PTC. Methods: Using β-galactoside-binding protein galectin-3 (Gal-3) overexpressed on the surface of highly invasive PTC cells as a target, C12 polypeptide (ANTPCGPYTHDCPVKR) with high affinity and specificity for Gal-3 was coupled to the surface of lipid microbubbles to prepare targeted microbubbles (Gal-3-C12@lipo MBs). The targeted microbubbles were prepared by thin-film hydration method and mechanical shaking method. The morphology, diameter, concentration and stability of microbubbles were investigated by fluorescence microscopy and an AccuSizer. The biosafety of microbubbles was studied using BCPAP cells through CCK8 assay. Confocal laser scanning microscope and flow cytometry were applied to research the cellular uptake of microbubbles to investigate the targeting ability to highly aggressive PTC. Finally, the specific contrast-enhanced ultrasound imaging of microbubbles in highly invasive PTC was validated on the mice bearing subcutaneous BCPAP tumor model via a clinically ultrasound imaging system. Results: Gal-3-C12@lipo MBs were successfully prepared which showed a well-defined spherical morphology with an average diameter of 1.598 ± 0.848 μm. Gal-3-C12@lipo MBs showed good stability without rupture within 4 hours after preparation. At the cellular level, Gal-3-C12@lipo MBs exhibited favorable biosafety and superior targeting ability to BCPAP cells, with 2.8-fold higher cellular uptake than non-targeted lipid microbubbles (Lipo MBs). At the animal level, Gal-3-C12@lipo MBs significantly improved the quality of contrast-enhanced ultrasound imaging in highly invasive PTC, with an echo intensity of tumor significantly higher than that of Lipo MBs. Conclusion: We designed and fabricated a novel targeted microbubble for the specific ultrasound imaging diagnosis of highly aggressive PTC. The targeted microbubbles have good stability, superior biosafety and high targeting specificity, which can significantly improve the tumor signal-to-noise ratio of highly invasive PTC, and have the potential to facilitate and accurately diagnose highly invasive PTC.

Preparation of Ultrasound Contrast Agent Microbubbles Combining Anti-MUC 1 Monoclone Antibody and Evaluation of Targeting Capability in Vitro

Preparation and Antitumor Activity of Bfgf-Mediated Active Targeting Doxorubicin Microbubbles

Experiment on the Factors for Enhancing the Susceptibility of Cancer Cells to Chemotherapeutic Drug by Ultrasound Microbubbles.

Microbubbles Conjoining LyP-1 as a Tumor Probe for Ultrasound Molecular Imaging: Targeting Efficiency Evaluation on Microfluidic Platform

Preparation of Vascular Endothelial Growth Factor Receptor 2/integrinαv Β3 Dual‐targeted Contrast Ultrasound Agent and Its Ultrasound Imaging Features and Targeted Ability :A in Vitro Study

Lyp-1 Ultrasonic Microbubbles Targeting To Cancer Cell As Tumor Bio-Acoustics Markers Or Drug Carriers: Targeting Efficiency Evaluation In Microfluidic Channels

Preparation of vascular endothelial growth factor receptor 2-targeted ultrasonic contrast agent and its ability oftargeting tumor cellsin vitro

Preparation of Lipid Nano-Bubbles as Contrast Agent Material for Tumor Ultrasound Diagnosis of Breast Cancer

Microfluidic-Assisted Formation of Multifunctional Monodisperse Microbubbles for Diagnostics and Therapeutics

Preparation of Targeted Nano-Microbubble Contrast Agent and Its Application in the Diagnosis of Prostate Cancer

Preparation and targeting study of Herceptin loaded PLGA-COOH-targeted ultrasound contrast agent

Preparation of Targeted High Molecular Polymer Microbubble Encapsuling Quantum Dots and Cell Experiment Study in Vitro

Preparation of Polyelectrolyte Multilayer Coated Microbubbles for Use as Ultrasound Contrast Agent

Preparation and Imaging Investigation of Dual-targeted C3F8-filled PLGA Nanobubbles as a Novel Ultrasound Contrast Agent for Breast Cancer

Preparation of BST2 Targeted Ultrasound Contrast Agent and Its in Vitro Binding with Tumor Cells

Dual-Mode Contrast Agents with RGD-Modified Polymer for Tumour-Targeted US/NIRF Imaging

Contrast-enhanced ultrasound combined targeted microbubbles for diagnosis of highly aggressive papillary thyroid carcinoma

Ultrasound targeting of microbubble-bound anti PD-L1 mAb to enhance anti-tumor effect of cisplatin in cervical cancer xenografts treatment

Multifunctional Nanoparticles for Combining Ultrasonic Tumor Imaging and Targeted Chemotherapy

Fabricating Multifunctional Microbubbles and Nanobubbles for Concurrent Ultrasound and Photoacoustic Imaging

Preparation of anti-HER-2 antibody PLGA polymer nano- ultrasound contrast agent In vitro targeting experiment